0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Therapy Medicine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-1K14340
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Gene Therapy Medicine Market Research Report 2023
BUY CHAPTERS

Global Gene Therapy Medicine Market Research Report 2025

Code: QYRE-Auto-1K14340
Report
July 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Gene Therapy Medicine Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Gene Therapy Medicine Market

Gene Therapy Medicine Market

The global market for Gene Therapy Medicine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Gene Therapy Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Therapy Medicine.
The Gene Therapy Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Gene Therapy Medicine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gene Therapy Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Gene Therapy Medicine Market Report

Report Metric Details
Report Name Gene Therapy Medicine Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc., Advantagene
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Gene Therapy Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Gene Therapy Medicine Market report?

Ans: The main players in the Gene Therapy Medicine Market are Bluebird Bio, Sangamo, Spark Therapeutics, Dimension Therapeutics, Avalanche Bio, Celladon, Vical Inc., Advantagene

What are the Application segmentation covered in the Gene Therapy Medicine Market report?

Ans: The Applications covered in the Gene Therapy Medicine Market report are Cancer, Monogenic, Infectious Disease, Cardiovascular Disease, Other

What are the Type segmentation covered in the Gene Therapy Medicine Market report?

Ans: The Types covered in the Gene Therapy Medicine Market report are Oral, Injection

Recommended Reports

Gene Therapy Markets

Cell & Regenerative Medicine

Precision & Delivery Solutions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gene Therapy Medicine Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Gene Therapy Medicine Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Cancer
1.3.3 Monogenic
1.3.4 Infectious Disease
1.3.5 Cardiovascular Disease
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gene Therapy Medicine Market Perspective (2020-2031)
2.2 Global Gene Therapy Medicine Growth Trends by Region
2.2.1 Global Gene Therapy Medicine Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Gene Therapy Medicine Historic Market Size by Region (2020-2025)
2.2.3 Gene Therapy Medicine Forecasted Market Size by Region (2026-2031)
2.3 Gene Therapy Medicine Market Dynamics
2.3.1 Gene Therapy Medicine Industry Trends
2.3.2 Gene Therapy Medicine Market Drivers
2.3.3 Gene Therapy Medicine Market Challenges
2.3.4 Gene Therapy Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gene Therapy Medicine Players by Revenue
3.1.1 Global Top Gene Therapy Medicine Players by Revenue (2020-2025)
3.1.2 Global Gene Therapy Medicine Revenue Market Share by Players (2020-2025)
3.2 Global Gene Therapy Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Gene Therapy Medicine Revenue
3.4 Global Gene Therapy Medicine Market Concentration Ratio
3.4.1 Global Gene Therapy Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy Medicine Revenue in 2024
3.5 Global Key Players of Gene Therapy Medicine Head office and Area Served
3.6 Global Key Players of Gene Therapy Medicine, Product and Application
3.7 Global Key Players of Gene Therapy Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy Medicine Breakdown Data by Type
4.1 Global Gene Therapy Medicine Historic Market Size by Type (2020-2025)
4.2 Global Gene Therapy Medicine Forecasted Market Size by Type (2026-2031)
5 Gene Therapy Medicine Breakdown Data by Application
5.1 Global Gene Therapy Medicine Historic Market Size by Application (2020-2025)
5.2 Global Gene Therapy Medicine Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Gene Therapy Medicine Market Size (2020-2031)
6.2 North America Gene Therapy Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Gene Therapy Medicine Market Size by Country (2020-2025)
6.4 North America Gene Therapy Medicine Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gene Therapy Medicine Market Size (2020-2031)
7.2 Europe Gene Therapy Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Gene Therapy Medicine Market Size by Country (2020-2025)
7.4 Europe Gene Therapy Medicine Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gene Therapy Medicine Market Size (2020-2031)
8.2 Asia-Pacific Gene Therapy Medicine Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Gene Therapy Medicine Market Size by Region (2020-2025)
8.4 Asia-Pacific Gene Therapy Medicine Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gene Therapy Medicine Market Size (2020-2031)
9.2 Latin America Gene Therapy Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Gene Therapy Medicine Market Size by Country (2020-2025)
9.4 Latin America Gene Therapy Medicine Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gene Therapy Medicine Market Size (2020-2031)
10.2 Middle East & Africa Gene Therapy Medicine Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Gene Therapy Medicine Market Size by Country (2020-2025)
10.4 Middle East & Africa Gene Therapy Medicine Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bluebird Bio
11.1.1 Bluebird Bio Company Details
11.1.2 Bluebird Bio Business Overview
11.1.3 Bluebird Bio Gene Therapy Medicine Introduction
11.1.4 Bluebird Bio Revenue in Gene Therapy Medicine Business (2020-2025)
11.1.5 Bluebird Bio Recent Development
11.2 Sangamo
11.2.1 Sangamo Company Details
11.2.2 Sangamo Business Overview
11.2.3 Sangamo Gene Therapy Medicine Introduction
11.2.4 Sangamo Revenue in Gene Therapy Medicine Business (2020-2025)
11.2.5 Sangamo Recent Development
11.3 Spark Therapeutics
11.3.1 Spark Therapeutics Company Details
11.3.2 Spark Therapeutics Business Overview
11.3.3 Spark Therapeutics Gene Therapy Medicine Introduction
11.3.4 Spark Therapeutics Revenue in Gene Therapy Medicine Business (2020-2025)
11.3.5 Spark Therapeutics Recent Development
11.4 Dimension Therapeutics
11.4.1 Dimension Therapeutics Company Details
11.4.2 Dimension Therapeutics Business Overview
11.4.3 Dimension Therapeutics Gene Therapy Medicine Introduction
11.4.4 Dimension Therapeutics Revenue in Gene Therapy Medicine Business (2020-2025)
11.4.5 Dimension Therapeutics Recent Development
11.5 Avalanche Bio
11.5.1 Avalanche Bio Company Details
11.5.2 Avalanche Bio Business Overview
11.5.3 Avalanche Bio Gene Therapy Medicine Introduction
11.5.4 Avalanche Bio Revenue in Gene Therapy Medicine Business (2020-2025)
11.5.5 Avalanche Bio Recent Development
11.6 Celladon
11.6.1 Celladon Company Details
11.6.2 Celladon Business Overview
11.6.3 Celladon Gene Therapy Medicine Introduction
11.6.4 Celladon Revenue in Gene Therapy Medicine Business (2020-2025)
11.6.5 Celladon Recent Development
11.7 Vical Inc.
11.7.1 Vical Inc. Company Details
11.7.2 Vical Inc. Business Overview
11.7.3 Vical Inc. Gene Therapy Medicine Introduction
11.7.4 Vical Inc. Revenue in Gene Therapy Medicine Business (2020-2025)
11.7.5 Vical Inc. Recent Development
11.8 Advantagene
11.8.1 Advantagene Company Details
11.8.2 Advantagene Business Overview
11.8.3 Advantagene Gene Therapy Medicine Introduction
11.8.4 Advantagene Revenue in Gene Therapy Medicine Business (2020-2025)
11.8.5 Advantagene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Gene Therapy Medicine Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Oral
 Table 3. Key Players of Injection
 Table 4. Global Gene Therapy Medicine Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Gene Therapy Medicine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Gene Therapy Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Gene Therapy Medicine Market Share by Region (2020-2025)
 Table 8. Global Gene Therapy Medicine Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Gene Therapy Medicine Market Share by Region (2026-2031)
 Table 10. Gene Therapy Medicine Market Trends
 Table 11. Gene Therapy Medicine Market Drivers
 Table 12. Gene Therapy Medicine Market Challenges
 Table 13. Gene Therapy Medicine Market Restraints
 Table 14. Global Gene Therapy Medicine Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Gene Therapy Medicine Market Share by Players (2020-2025)
 Table 16. Global Top Gene Therapy Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Medicine as of 2024)
 Table 17. Ranking of Global Top Gene Therapy Medicine Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Gene Therapy Medicine Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Gene Therapy Medicine, Headquarters and Area Served
 Table 20. Global Key Players of Gene Therapy Medicine, Product and Application
 Table 21. Global Key Players of Gene Therapy Medicine, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Gene Therapy Medicine Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Gene Therapy Medicine Revenue Market Share by Type (2020-2025)
 Table 25. Global Gene Therapy Medicine Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Gene Therapy Medicine Revenue Market Share by Type (2026-2031)
 Table 27. Global Gene Therapy Medicine Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Gene Therapy Medicine Revenue Market Share by Application (2020-2025)
 Table 29. Global Gene Therapy Medicine Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Gene Therapy Medicine Revenue Market Share by Application (2026-2031)
 Table 31. North America Gene Therapy Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Gene Therapy Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Gene Therapy Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Gene Therapy Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Gene Therapy Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Gene Therapy Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Gene Therapy Medicine Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Gene Therapy Medicine Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Gene Therapy Medicine Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Gene Therapy Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Gene Therapy Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Gene Therapy Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Gene Therapy Medicine Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Gene Therapy Medicine Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Gene Therapy Medicine Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Bluebird Bio Company Details
 Table 47. Bluebird Bio Business Overview
 Table 48. Bluebird Bio Gene Therapy Medicine Product
 Table 49. Bluebird Bio Revenue in Gene Therapy Medicine Business (2020-2025) & (US$ Million)
 Table 50. Bluebird Bio Recent Development
 Table 51. Sangamo Company Details
 Table 52. Sangamo Business Overview
 Table 53. Sangamo Gene Therapy Medicine Product
 Table 54. Sangamo Revenue in Gene Therapy Medicine Business (2020-2025) & (US$ Million)
 Table 55. Sangamo Recent Development
 Table 56. Spark Therapeutics Company Details
 Table 57. Spark Therapeutics Business Overview
 Table 58. Spark Therapeutics Gene Therapy Medicine Product
 Table 59. Spark Therapeutics Revenue in Gene Therapy Medicine Business (2020-2025) & (US$ Million)
 Table 60. Spark Therapeutics Recent Development
 Table 61. Dimension Therapeutics Company Details
 Table 62. Dimension Therapeutics Business Overview
 Table 63. Dimension Therapeutics Gene Therapy Medicine Product
 Table 64. Dimension Therapeutics Revenue in Gene Therapy Medicine Business (2020-2025) & (US$ Million)
 Table 65. Dimension Therapeutics Recent Development
 Table 66. Avalanche Bio Company Details
 Table 67. Avalanche Bio Business Overview
 Table 68. Avalanche Bio Gene Therapy Medicine Product
 Table 69. Avalanche Bio Revenue in Gene Therapy Medicine Business (2020-2025) & (US$ Million)
 Table 70. Avalanche Bio Recent Development
 Table 71. Celladon Company Details
 Table 72. Celladon Business Overview
 Table 73. Celladon Gene Therapy Medicine Product
 Table 74. Celladon Revenue in Gene Therapy Medicine Business (2020-2025) & (US$ Million)
 Table 75. Celladon Recent Development
 Table 76. Vical Inc. Company Details
 Table 77. Vical Inc. Business Overview
 Table 78. Vical Inc. Gene Therapy Medicine Product
 Table 79. Vical Inc. Revenue in Gene Therapy Medicine Business (2020-2025) & (US$ Million)
 Table 80. Vical Inc. Recent Development
 Table 81. Advantagene Company Details
 Table 82. Advantagene Business Overview
 Table 83. Advantagene Gene Therapy Medicine Product
 Table 84. Advantagene Revenue in Gene Therapy Medicine Business (2020-2025) & (US$ Million)
 Table 85. Advantagene Recent Development
 Table 86. Research Programs/Design for This Report
 Table 87. Key Data Information from Secondary Sources
 Table 88. Key Data Information from Primary Sources
 Table 89. Authors List of This Report


List of Figures
 Figure 1. Gene Therapy Medicine Picture
 Figure 2. Global Gene Therapy Medicine Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Gene Therapy Medicine Market Share by Type: 2024 VS 2031
 Figure 4. Oral Features
 Figure 5. Injection Features
 Figure 6. Global Gene Therapy Medicine Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Gene Therapy Medicine Market Share by Application: 2024 VS 2031
 Figure 8. Cancer Case Studies
 Figure 9. Monogenic Case Studies
 Figure 10. Infectious Disease Case Studies
 Figure 11. Cardiovascular Disease Case Studies
 Figure 12. Other Case Studies
 Figure 13. Gene Therapy Medicine Report Years Considered
 Figure 14. Global Gene Therapy Medicine Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Gene Therapy Medicine Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Gene Therapy Medicine Market Share by Region: 2024 VS 2031
 Figure 17. Global Gene Therapy Medicine Market Share by Players in 2024
 Figure 18. Global Top Gene Therapy Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy Medicine as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Gene Therapy Medicine Revenue in 2024
 Figure 20. North America Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Gene Therapy Medicine Market Share by Country (2020-2031)
 Figure 22. United States Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Gene Therapy Medicine Market Share by Country (2020-2031)
 Figure 26. Germany Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Gene Therapy Medicine Market Share by Region (2020-2031)
 Figure 34. China Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Gene Therapy Medicine Market Share by Country (2020-2031)
 Figure 42. Mexico Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Gene Therapy Medicine Market Share by Country (2020-2031)
 Figure 46. Turkey Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Gene Therapy Medicine Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Bluebird Bio Revenue Growth Rate in Gene Therapy Medicine Business (2020-2025)
 Figure 50. Sangamo Revenue Growth Rate in Gene Therapy Medicine Business (2020-2025)
 Figure 51. Spark Therapeutics Revenue Growth Rate in Gene Therapy Medicine Business (2020-2025)
 Figure 52. Dimension Therapeutics Revenue Growth Rate in Gene Therapy Medicine Business (2020-2025)
 Figure 53. Avalanche Bio Revenue Growth Rate in Gene Therapy Medicine Business (2020-2025)
 Figure 54. Celladon Revenue Growth Rate in Gene Therapy Medicine Business (2020-2025)
 Figure 55. Vical Inc. Revenue Growth Rate in Gene Therapy Medicine Business (2020-2025)
 Figure 56. Advantagene Revenue Growth Rate in Gene Therapy Medicine Business (2020-2025)
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS